Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma

Huiquan Gu; Xinzheng Gao; Wenlong Han; Fangyu Wang; Hanqiang Zhang; Longyu Yao; Weimin Chen; Qiang Liu

doi:10.1186/s12920-024-02019-x

ScienceGate Book Chapters

JOURNAL ARTICLE

Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma

Huiquan Gu Xinzheng Gao Wenlong Han Fangyu Wang Hanqiang Zhang Longyu Yao Weimin Chen Qiang Liu

Year: 2024 Journal: BMC Medical Genomics Vol: 17 (1)Pages: 265-265 Publisher: BioMed Central

DOI: 10.1186/s12920-024-02019-x

Get Full-Text PDF Get Analytical Report

Keywords:

Drug Human genetics Adenocarcinoma Lung Adenocarcinoma of the lung Cancer research Oncology Internal medicine Medicine Biology Lung cancer Bioinformatics Pharmacology Genetics Cancer Gene

Metrics

Cited By

0.54

FWCI (Field Weighted Citation Impact)

Refs

0.68

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Peptidase Inhibition and Analysis

Health Sciences → Medicine → Oncology

Epigenetics and DNA Methylation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Cancer-related gene regulation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Molecular Biology

Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma

Metrics

Citation History

Topics

Related Documents

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma

Cell division cycle 20 overexpression predicts poor prognosis for patients with lung adenocarcinoma

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer

Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma

DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma